Literature DB >> 19273299

Biochemical characterization of riboflavin carrier protein (RCP) in prostate cancer.

Tanya Johnson1, Allal Ouhtit, Rajiv Gaur, Augusta Fernando, Paul Schwarzenberger, Joseph Su, Mohamed F Ismail, Hassan I El-Sayyad, Anjali Karande, Zakaria Abd Elmageed, Prakash Rao, Madhwa Raj.   

Abstract

Riboflavin carrier protein (RCP) is a growth- and development-specific protein. Here, we characterized the expression of this protein in prostate cancer by polyclonal and monoclonal antibodies against chicken RCP. RCP was localized to both androgen-dependent and independent prostate cancer cell lines. Compared to controls, RCP was over-expressed in all 45 prostate adenocarcinomas, irrespective of the Gleason's score or the stage of the disease. The identified RCP had a molecular weight of 38 kDa, similar to RCP purified from chicken. Presence of this protein was also confirmed by siRNA inhibition analysis. Antibodies to chicken RCP inhibited incorporation of tritiated thymidine into DNA and prevented riboflavin uptake in PC3 prostate cancer cells, suggesting a critical function of this protein in prostate cancer cell growth. These data suggest that RCP can be used as a tumor biomarker in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273299     DOI: 10.2741/3477

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  7 in total

1.  Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study.

Authors:  Anna Plantinga; Amanda Witte; Ming-Hsin Li; Andrew Harmon; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  ACS Med Chem Lett       Date:  2011-05-12       Impact factor: 4.345

2.  Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.

Authors:  Amanda B Witte; Christine M Timmer; Jeremy J Gam; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  Biomacromolecules       Date:  2012-01-18       Impact factor: 6.988

3.  Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery.

Authors:  Thommey P Thomas; Seok Ki Choi; Ming-Hsin Li; Alina Kotlyar; James R Baker
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

4.  Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.

Authors:  Nataliia Beztsinna; Yoanna Tsvetkova; Jithin Jose; Boutayna Rhourri-Frih; Wa'el Al Rawashdeh; Twan Lammers; Fabian Kiessling; Isabelle Bestel
Journal:  Int J Nanomedicine       Date:  2017-05-18

Review 5.  Riboflavin-Targeted Drug Delivery.

Authors:  Milita Darguzyte; Natascha Drude; Twan Lammers; Fabian Kiessling
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

6.  Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells.

Authors:  Wid Mekseriwattana; Pablo Guardia; Beatriz Torres Herrero; Jesus M de la Fuente; Chutima Kuhakarn; Anna Roig; Kanlaya Prapainop Katewongsa
Journal:  Nanoscale Adv       Date:  2022-03-02

7.  Atomic force microscopy probing of receptor-nanoparticle interactions for riboflavin receptor targeted gold-dendrimer nanocomposites.

Authors:  Amanda B Witte; Abigail N Leistra; Pamela T Wong; Sophia Bharathi; Kevin Refior; Phillip Smith; Ola Kaso; Kumar Sinniah; Seok Ki Choi
Journal:  J Phys Chem B       Date:  2014-03-07       Impact factor: 2.991

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.